Evidence map›Paper›PMID 27975070›Full record

ArticleJournal of immunology research2016

Overexpression of MMP-3 and uPA with Diminished PAI-1 Related to Metastasis in Ductal Breast Cancer Patients Attending a Public Hospital in Mexico City.

Luis Miguel Barajas-Castañeda, Evelin Cortés-Gutiérrez, Francisco Mario García-Rodríguez, Rafael Campos-Rodríguez, Eleazar Lara-Padilla, Fernando Enríquez-Rincón, María Eugenia Castro-Mussot, Paula Figueroa-Arredondo

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Luis Miguel Barajas-CastañedaDepartamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, 11340 Mexico City, Mexico.
Evelin Cortés-GutiérrezServicio de Anatomía Patológica, Hospital Juárez de México, Secretaría de Salud, Av. Instituto Politécnico Nacional 5160, 07760 Mexico City, Mexico.
Francisco Mario García-RodríguezUnidad de Oncología, Hospital Juárez de México, Secretaría de Salud, Av. Instituto Politécnico Nacional 5160, 07760 Mexico City, Mexico.
Rafael Campos-RodríguezDepartamento de Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Salvador Díaz Mirón S/N, 11340 Mexico City, Mexico.
Eleazar Lara-PadillaDepartamento de Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Salvador Díaz Mirón S/N, 11340 Mexico City, Mexico.
Fernando Enríquez-RincónLaboratorio Nacional de Servicios Experimentales (LaNSE), Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional, Av. Instituto Politécnico Nacional 2508, 07360 Mexico City, Mexico.
María Eugenia Castro-MussotDepartamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, 11340 Mexico City, Mexico.ORCID 0000-0002-8924-5607
Paula Figueroa-ArredondoDepartamento de Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Salvador Díaz Mirón S/N, 11340 Mexico City, Mexico.
Instituto Politécnico Nacional · MXSecretaria de Salud · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular matrix metalloproteases and the fibrinolytic system are important protease systems interacting with each other in charge of remodeling and recycling of tissues. Their role in tumor invasion and metastasis is often discussed. In this study several metalloproteases such as MMP-1, MMP-3, MMP-9, and TIMP-1 together with molecules from the fibrinolytic system like uPA, its receptor uPAR, and its inhibitor, PAI-1, were studied by immune-histochemistry to establish a comparison with and without metastasis. From the (118) primary tumors of Mexican patients with ductal breast cancer studied, 56% were grade II and 69% were size T2; the group with metastatic ganglia included 64 samples (54.3%). In patients with metastasis the estimated expression of MMP-3 and uPA (resp., 28% and 45%) was higher than that from no metastatic tumors; it means there is higher expression of both markers in metastatic tumors (

Indexed as

AdultAgedBiomarkers, TumorBreast NeoplasmsCarcinoma, Ductal, BreastFemaleGene ExpressionHospitalizationHumansMatrix Metalloproteinase 3Matrix MetalloproteinasesMexicoMiddle AgedNeoplasm GradingNeoplasm MetastasisNeoplasm StagingBiomarkers, TumorMatrix Metalloproteinase 3Matrix MetalloproteinasesPlasminogen Activator Inhibitor 1Urokinase-Type Plasminogen Activator

Identifiers

PMID27975070
PMCPMC5126427
OpenAlexW2555729723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.